Recent advances in the discovery and development of drugs targeting the kallikrein-kinin system.

Petra WisniewskiTanja GangnusBjoern Bengt Burckhardt

Published in: Journal of translational medicine (2024)

The therapeutic impact of targeting the kallikrein-kinin system is no longer limited to the treatment of hereditary angioedema. Ongoing research on other diseases demonstrates the potential of therapeutic interventions targeting the kallikrein-kinin system and will provide further treatment options for patients in the future.

Keyphrases

cancer therapy
end stage renal disease
newly diagnosed
ejection fraction
peritoneal dialysis
small molecule
prognostic factors
drug delivery
high throughput
patient reported outcomes
risk assessment
human health
patient reported
climate change
single cell
replacement therapy